Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Carpenter

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cardiology in the Young|September 25, 2024
Analysis of ST segment alarms in children admitted to the paediatric and cardiac intensive care units and cardiac progressive care unit: a single-centre retrospective studyChristine Peyton Gallagher, Sonja I Ziniel, Jennifer Newman, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2023
Novel VMAT planning technique improves dosimetry for head and neck cancer patients undergoing definitive chemoradiotherapyDavid DiBartolo, Todd Carpenter, Joseph P Santoro, et al.
Radiation Oncology (London, England)|July 10, 2021
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel diseaseJonathan W Lischalk, Seth Blacksburg, Christopher Mendez, et al.
Frontiers in Oncology|April 24, 2023
Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|April 24, 2023
Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|February 27, 2024
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiationJonathan W Lischalk, Meredith Akerman, Michael C Repka, et al.
Radiation Oncology (London, England)|April 3, 2022
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRIKatherine Amarell, Anna Jaysing, Christopher Mendez, et al.
Radiation Oncology (London, England)|October 1, 2025
Fiducial tracking fidelity in robotic prostate SBRT: a comparison of a 3-fraction boost following pelvic nodal irradiation and definitive 5-fraction treatmentJonathan W Lischalk, Vianca F Santos, Brianna Vizcaino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
High-volume biopsy core involvement is not associated with failure after SBRT monotherapy for intermediate-risk prostate cancerJoshua C Hurwitz, Jonathan A Haas, Vianca F Santos, et al.
Practical Radiation Oncology|November 20, 2023
Stereotactic Body Radiation Therapy for the Curative Treatment of Prostate Cancer in Ultralarge (≥100 cc) GlandsJoshua C Hurwitz, Jonathan Haas, Christopher Mendez, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cardiology in the Young|September 25, 2024
Analysis of ST segment alarms in children admitted to the paediatric and cardiac intensive care units and cardiac progressive care unit: a single-centre retrospective studyChristine Peyton Gallagher, Sonja I Ziniel, Jennifer Newman, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2023
Novel VMAT planning technique improves dosimetry for head and neck cancer patients undergoing definitive chemoradiotherapyDavid DiBartolo, Todd Carpenter, Joseph P Santoro, et al.
Radiation Oncology (London, England)|July 10, 2021
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel diseaseJonathan W Lischalk, Seth Blacksburg, Christopher Mendez, et al.
Frontiers in Oncology|April 24, 2023
Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|April 24, 2023
Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|February 27, 2024
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiationJonathan W Lischalk, Meredith Akerman, Michael C Repka, et al.
Radiation Oncology (London, England)|April 3, 2022
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRIKatherine Amarell, Anna Jaysing, Christopher Mendez, et al.
Radiation Oncology (London, England)|October 1, 2025
Fiducial tracking fidelity in robotic prostate SBRT: a comparison of a 3-fraction boost following pelvic nodal irradiation and definitive 5-fraction treatmentJonathan W Lischalk, Vianca F Santos, Brianna Vizcaino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
High-volume biopsy core involvement is not associated with failure after SBRT monotherapy for intermediate-risk prostate cancerJoshua C Hurwitz, Jonathan A Haas, Vianca F Santos, et al.
Practical Radiation Oncology|November 20, 2023
Stereotactic Body Radiation Therapy for the Curative Treatment of Prostate Cancer in Ultralarge (≥100 cc) GlandsJoshua C Hurwitz, Jonathan Haas, Christopher Mendez, et al.
Pageof 3